Los Angeles based Capricor Therapeutics, Inc. CAPR is a clinical stage biotechnology company focused on the development and commercialization of regenerative medicine and large molecule products for the treatment of diseases. The Company has six drug candidates in stages of development which includes CAP , CAP , CSps, Exosomes, Cenderitide and CU NP. Capricor s lead product candidate, an allogeneic cardiosphere derived cell CDC product, CAP , aims to attenuate and potentially improve damage to the heart caused by a heart attack and is currently under evaluation in the Phase I/II ALLSTAR clinical trial of patients days to year after a heart attack. Ongoing research at Capricor focuses on in depth product characterization, expanded use of current products, development of next generation products, and identification of new technologies. The company was founded in and is headquartered in Beverly Hills, CA.
Quote | Capricor Therapeutics Inc. (NASDAQ:CAPR)
Last: | $5.05 |
---|---|
Change Percent: | -0.9% |
Open: | $5.6 |
Close: | $5.05 |
High: | $5.65 |
Low: | $4.685 |
Volume: | 931,030 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Capricor Therapeutics Inc. (NASDAQ:CAPR)
2024-04-01 10:17:11 ET More on Solid Biosciences Solid Biosciences: DMD Treatment Advancement With Next-Generation Capsid William Blair starts Solid Biosciences at outperform Piper Sandler upgrades Solid Biosciences to overweight Seeking Alpha’s Quant ...
2024-03-22 10:00:33 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...
Message Board Posts | Capricor Therapeutics Inc. (NASDAQ:CAPR)
Subject | By | Source | When |
---|---|---|---|
Capricor Announces Peer-Reviewed Publication Demonstrating the Therapeutic Po | staynafloat | investorshub | 04/27/2023 1:22:47 PM |
Patience will pay off huge soon I am holding | Volcano | investorshub | 04/03/2023 11:00:30 PM |
Capr. If you go back about 2 years | ed3/6me | investorshub | 03/26/2023 9:03:03 PM |
I would say BLA submission this summer Pps will | Volcano | investorshub | 03/18/2023 5:32:30 PM |
This one will run 1000% in the coming | Volcano | investorshub | 03/16/2023 12:32:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Capricor Therapeutics Inc. Company Name:
CAPR Stock Symbol:
NASDAQ Market:
Capricor Therapeutics Inc. Website:
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and ex...
2024-03-18 12:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, announced today that the Company will present the positive 24-month ...